433 related articles for article (PubMed ID: 31606701)
1. CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells.
Guo Z; Liu Y; Zhou H; Zheng K; Wang D; Jia M; Xu P; Ma K; Cui C; Wang L
Colloids Surf B Biointerfaces; 2019 Dec; 184():110546. PubMed ID: 31606701
[TBL] [Abstract][Full Text] [Related]
2. Improving the photothermal therapy efficacy and preventing the surface oxidation of bismuth nanoparticles through the formation of a bismuth@bismuth selenide heterostructure.
Li B; Cheng Y; Zheng R; Wu X; Qi F; Wu Y; Hu Y; Li X
J Mater Chem B; 2020 Oct; 8(38):8803-8808. PubMed ID: 32857100
[TBL] [Abstract][Full Text] [Related]
3. One-Pot Synthesis of a Bismuth Selenide Hexagon Nanodish Complex for Multimodal Imaging-Guided Combined Antitumor Phototherapy.
Song Y; Wang J; Liu L; Sun Q; You Q; Cheng Y; Wang Y; Wang S; Tan F; Li N
Mol Pharm; 2018 May; 15(5):1941-1953. PubMed ID: 29608315
[TBL] [Abstract][Full Text] [Related]
4. Achieving traceless ablation of solid tumors without recurrence by mild photothermal-chemotherapy of triple stimuli-responsive polymer-drug conjugate nanoparticles.
Du C; Ding Y; Qian J; Zhang R; Dong CM
J Mater Chem B; 2019 Jan; 7(3):415-432. PubMed ID: 32254729
[TBL] [Abstract][Full Text] [Related]
5. C-C Chemokine Ligand 2 (CCL2) Recruits Macrophage-Membrane-Camouflaged Hollow Bismuth Selenide Nanoparticles To Facilitate Photothermal Sensitivity and Inhibit Lung Metastasis of Breast Cancer.
Zhao H; Li L; Zhang J; Zheng C; Ding K; Xiao H; Wang L; Zhang Z
ACS Appl Mater Interfaces; 2018 Sep; 10(37):31124-31135. PubMed ID: 30141614
[TBL] [Abstract][Full Text] [Related]
6. Construct of MoSe
Wang Y; Zhao J; Chen Z; Zhang F; Wang Q; Guo W; Wang K; Lin H; Qu F
Biomaterials; 2019 Oct; 217():119282. PubMed ID: 31260884
[TBL] [Abstract][Full Text] [Related]
7. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-Targeting MoS
Li X; Xiao H; Xiu W; Yang K; Zhang Y; Yuwen L; Yang D; Weng L; Wang L
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55928-55938. PubMed ID: 34786942
[TBL] [Abstract][Full Text] [Related]
9. Responsive functionalized MoSe
Liu Y; Wei C; Lin A; Pan J; Chen X; Zhu X; Gong Y; Yuan G; Chen L; Liu J; Luo Z
Colloids Surf B Biointerfaces; 2020 May; 189():110820. PubMed ID: 32045843
[TBL] [Abstract][Full Text] [Related]
10. Multi-stimuli responsive mesoporous carbon nano-platform gated by human serum albumin for cancer thermo-chemotherapy.
Zhao Q; Wang X; Yang M; Li X; Mao Y; Guan X; Di D; Wang S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110532. PubMed ID: 31590051
[TBL] [Abstract][Full Text] [Related]
11. Cancer immunotherapy targeting the CD47/SIRPα axis.
Weiskopf K
Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
[TBL] [Abstract][Full Text] [Related]
12. Carambola-like Bi
Zhao Y; Liu Y; Wang Q; Liu J; Zhang S; Zhang T; Wang D; Wang Y; Jin L; Zhang H
J Mater Chem B; 2021 Sep; 9(35):7271-7277. PubMed ID: 34121105
[TBL] [Abstract][Full Text] [Related]
13. Boron-based nanosheets for combined cancer photothermal and photodynamic therapy.
Kang Y; Ji X; Li Z; Su Z; Zhang S
J Mater Chem B; 2020 Jun; 8(21):4609-4619. PubMed ID: 32373909
[TBL] [Abstract][Full Text] [Related]
14. Polypeptide-Conjugated Second Near-Infrared Organic Fluorophore for Image-Guided Photothermal Therapy.
Li T; Li C; Ruan Z; Xu P; Yang X; Yuan P; Wang Q; Yan L
ACS Nano; 2019 Mar; 13(3):3691-3702. PubMed ID: 30790523
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
[TBL] [Abstract][Full Text] [Related]
16. A mitochondria-targeted thiazoleorange-based photothermal agent for enhanced photothermal therapy for tumors.
Bian W; Pan Z; Wang Y; Long W; Chen Z; Chen N; Zeng Y; Yuan J; Liu X; Lu YJ; He Y; Zhang K
Bioorg Chem; 2021 Aug; 113():104954. PubMed ID: 34023651
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging.
Li Z; Hu Y; Howard KA; Jiang T; Fan X; Miao Z; Sun Y; Besenbacher F; Yu M
ACS Nano; 2016 Jan; 10(1):984-97. PubMed ID: 26655250
[TBL] [Abstract][Full Text] [Related]
18. CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy.
Wang H; Sun Y; Zhou X; Chen C; Jiao L; Li W; Gou S; Li Y; Du J; Chen G; Zhai W; Wu Y; Qi Y; Gao Y
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020240
[TBL] [Abstract][Full Text] [Related]
19. Versatile activatable vSIRPα-probe for cancer-targeted imaging and macrophage-mediated phagocytosis of cancer cells.
Ko YJ; Lee JW; Kim H; Cho E; Yang Y; Kim IS; Kim SH; Kwon IC
J Control Release; 2020 Jul; 323():376-386. PubMed ID: 32335154
[TBL] [Abstract][Full Text] [Related]
20. An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity.
Wang X; Wang Y; Hu J; Xu H
Cancer Med; 2021 Mar; 10(6):2125-2136. PubMed ID: 33629544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
